# Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

> **NCT07382505** · — · NOT_YET_RECRUITING · sponsor: **Asan Medical Center** · enrollment: 600 (estimated)

## Conditions studied

- Uterine Neoplasms
- Cervical Cancer

## Interventions

- **GENETIC:** Serial blood collection for MRD testing

## Key facts

- **NCT ID:** NCT07382505
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-15
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07382505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07382505, "Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT07382505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*